Figure 3A illustrates the eNOS-NO-sGC-cGMP-PKG pathway and its contribution to oxidative stress and insulin resistance in HFpEF patients with and without diabetes (Fig. )3B–H). Here, SGCB is linked to diabetes mellitus.